Wegovy and Ozempic are the same medication. Both contain semaglutide, a compound made by Novo Nordisk that mimics a gut hormone involved in blood sugar regulation and appetite. The key difference is why they’re prescribed: Ozempic is approved for type 2 diabetes, while Wegovy is approved for weight management. That distinction affects dosing, insurance coverage, and who qualifies for each one.
Same Drug, Different Approvals
Semaglutide works by activating a receptor for a natural hormone called GLP-1, which your body releases after eating. It slows digestion, helps regulate blood sugar, and reduces appetite by signaling fullness to the brain. Novo Nordisk is the only company in the United States with FDA-approved semaglutide products.
Ozempic is FDA-approved for three specific uses in adults with type 2 diabetes: improving blood sugar control alongside diet and exercise, reducing the risk of major cardiovascular events in people with established heart disease, and reducing kidney disease progression in people with chronic kidney disease. It is not approved for weight loss on its own.
Wegovy is FDA-approved for weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 to 29.9) with at least one weight-related condition such as high blood pressure or high cholesterol. It’s also approved for teens aged 12 and older with obesity. More recently, Wegovy gained additional approvals for cardiovascular risk reduction and a liver condition called non-cirrhotic MASH.
The Doses Are Significantly Different
This is where the practical gap between the two drugs becomes clear. Ozempic tops out at 2 mg per week. Wegovy’s standard maintenance dose is 2.4 mg per week, and for patients who need more, it can now go as high as 7.2 mg per week. Both medications use a gradual dose escalation, starting low and increasing over several months to reduce side effects like nausea.
That higher ceiling matters for weight loss. In the STEP 2 clinical trial, which studied people with both obesity and type 2 diabetes, participants on the 2.4 mg weekly dose lost an average of 9.6% of their body weight over 68 weeks, compared to 3.4% with a placebo. The greater semaglutide dose available through Wegovy is a major reason it produces more weight loss than what most people experience on Ozempic.
The Injection Pens Work Differently
Both drugs are weekly injections given under the skin, typically in the stomach, thigh, or upper arm. But the pens themselves aren’t identical.
Ozempic pens are multi-dose. Each pen holds enough medication for four or eight injections depending on the strength. You attach a new disposable needle before each use and turn a dial to select your dose. Wegovy pens are single-use. Each pen comes with a needle already attached and delivers one pre-set dose. You use it once, then dispose of it. Wegovy’s design is simpler per injection, but Ozempic’s multi-dose pen means fewer pens to manage over time.
Insurance Coverage Varies Widely
Getting Ozempic covered is generally more straightforward because most insurance plans cover diabetes medications. Wegovy faces steeper barriers because many insurers treat weight management drugs differently, and some employers exclude weight loss treatments from their plans entirely.
Among commercial health plans that do cover Wegovy, the requirements can be substantial. Nearly all require documented BMI thresholds matching the FDA label, and some set the bar even higher, only covering people with a BMI above 30 regardless of other conditions. Most plans also require that you’re following a reduced-calorie diet and exercise program. About two-thirds require enrollment in a behavioral modification program before or during treatment. One plan requires trying a different weight loss medication first.
Even after approval, coverage is often short-term. Approval periods range from 12 weeks to two years, and every plan that specifies continuation criteria requires documented weight loss of at least 4% to 5% from your starting weight to keep getting the medication. If you don’t hit that threshold, coverage can be cut off. This creates a practical reality where Wegovy requires ongoing proof that it’s working in order to stay covered.
Why People Use Ozempic for Weight Loss
Because Ozempic and Wegovy contain the same active ingredient, some doctors prescribe Ozempic off-label for weight loss, particularly when Wegovy is harder to get due to cost or availability. This is legal and common in medicine, but it means a lower maximum dose (2 mg instead of 2.4 mg or higher) and potentially less weight loss as a result.
Off-label use of Ozempic for weight loss also creates complications with insurance. A plan may cover Ozempic for diabetes but deny it if the prescribing reason is weight management. Some patients with type 2 diabetes who also want weight loss may find Ozempic covers both needs at once, though the dose ceiling remains lower than what Wegovy offers.
Side Effects Are the Same
Since the active ingredient is identical, the side effect profile is essentially the same for both medications. The most common issues are gastrointestinal: nausea, vomiting, diarrhea, constipation, and stomach pain. These tend to be worst during dose increases and often improve over time. The gradual dose escalation schedule for both drugs is specifically designed to minimize these effects.
More serious but rarer risks include inflammation of the pancreas, gallbladder problems, and a potential (studied only in animals) risk of thyroid tumors. Both carry the same boxed warning about a type of thyroid cancer seen in rodent studies, and neither should be used by people with a personal or family history of that specific cancer type or a condition called multiple endocrine neoplasia syndrome type 2.
Choosing Between Them
If you have type 2 diabetes, Ozempic is the standard starting point. It addresses blood sugar, cardiovascular risk, and kidney protection in one medication, and insurance coverage is relatively predictable. If your primary goal is weight loss and you meet the BMI criteria, Wegovy is the version specifically dosed and approved for that purpose. For people with type 2 diabetes who also want significant weight loss, the choice often comes down to which drug your insurance will cover and at what dose your doctor thinks you’ll benefit most.
The bottom line: Wegovy and Ozempic are the same molecule packaged and dosed for different medical goals. The chemistry in the pen is identical. What differs is how much you take, what it’s approved to treat, and how easily you can get it covered.